NEW YORK (GenomeWeb) – Illumina today announced agreements with three organizations for use of its next-generation sequencing technologies to develop and run non-invasive prenatal testing in parts of Europe.

Illumina's deals are with Biomnis, which plans to make NIPT available in France; with Genoma for NIPT services in Italy; and with the Center for Human Genetics and Laboratory Diagnostics, which will offer NIPT in Germany.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.